Vai al contenuto
Global sound
The Bio Report

The Bio Report

Making Opioids a Last Resort

· 36 min · Episodio 202

Note dell’episodio

Pain is one of medicine’s most common complaints, yet finding effective alternatives to opioids has proved remarkably difficult. Latigo Biotherapeutics is developing experimental medicines that target NaV1.8, a sodium channel involved in transmitting pain signals through peripheral nerves, with the goal of relieving pain without the addiction risk and other side effects associated with opioids. We spoke with Nima Farzan, CEO of Latigo, about the science behind the company’s approach to treating pain, what its clinical results suggest about the potential to reduce opioid use after surgery, and what clinicians and insurers will need to see beyond regulatory approval.

Sito web: thebioreport.podbean.com

In diretta, ultima ora: 13.728 brani su 7.051 stazioni in 145 paesi

Scopri il mondo attraverso la radio

Altri modi per scoprire (9)

Hai sentito qualcosa di bello? Salvalo, o aprilo subito in Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
Radio DeportesContinua ad ascoltare